Cyclacel Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.7439.630.970.63
Price/Sales ratio
1.50K3.740.680.46
Earnings per Share (EPS)
$-4.32$0.19$7.76$11.81

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-11.88-17.02-23.04-26.66-15.05-1.39-3.36-1.83-0.31-0.10-0.00-15.05
Price/Sales ratio
132.92125.60322.38N/A731.69N/AN/AN/AN/A5.40N/AN/A
Price/Book Value ratio
10.6212.9619.049.157.180.930.850.930.423.740.140.93
Price/Cash Flow ratio
-12.32-16.88-26.96-26.62-16.37-1.15-3.57-1.87-0.31-0.14-0.00-16.37
Price/Free Cash Flow ratio
-12.12-16.84-26.95-26.58-16.28-1.15-3.53-1.87-0.31-0.14-0.00-16.28
Price/Earnings Growth ratio
-0.370.330.660.370.39-0.000.040.20-0.200.000.02-0.00
Dividend Yield
0.08%0.08%0.07%0.10%0.18%1.83%0.70%0.57%3.05%8.84%N/A1.83%
Profitability Indicator Ratios
Gross Profit Margin
-954.03%-536.93%-1024.19%N/A-2784.66%N/AN/AN/AN/A100%N/A-2784.66%
Operating Profit Margin
-1293.94%-831.79%-1678.52%N/A-6365.33%N/AN/AN/AN/A-6060.23%N/A-6365.33%
Pretax Profit Margin
-1306.17%-848.04%-1633.92%N/A-5750%N/AN/AN/AN/A-6083.57%N/A-5750%
Net Profit Margin
-1118.05%-737.75%-1398.69%N/A-4858.66%N/AN/AN/AN/A-5370.23%N/A-4858.66%
Effective Tax Rate
14.31%13.00%14.39%11.73%15.50%14.21%12.76%16.92%18.20%11.72%19.54%15.50%
Return on Assets
-65.97%-57.91%-59.96%-28.72%-36.76%-51.13%-22.94%-44.34%-77.08%-256.16%-31637.41%-51.13%
Return On Equity
-89.39%-76.14%-82.61%-34.31%-47.72%-66.92%-25.39%-50.68%-136.68%-3715.81%-54.67%-66.92%
Return on Capital Employed
-102.48%-85.05%-98.24%-43.35%-62.11%-75.11%-30.99%-61.50%-137.53%-3952.32%-61385.44%-75.11%
Liquidity Ratios
Current Ratio
3.874.273.736.314.445.7914.26N/AN/AN/A3.305.79
Quick Ratio
3.724.103.546.194.305.5013.997.624.060.912.485.50
Cash ratio
3.223.553.145.813.934.9113.436.902.480.412.484.91
Days of Sales Outstanding
728.31568.15890.63N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
21.4228.5338.475.64K51.3712.82K12.48K4.89K-64.33KN/AN/A12.82K
Operating Cycle
749.74596.68929.11N/A51.37N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
55.7557.1896.1717.77K229.3516.24K9.38K17.96K29.21KN/AN/A16.24K
Cash Conversion Cycle
693.98539.50832.94N/A-177.98N/AN/AN/AN/AN/AN/A-177.98
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.27N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.48N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-587.80N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.351.311.371.191.291.301.101.141.7714.501.771.29
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-10.78-7.43-11.95N/A-44.67N/AN/AN/AN/A-38.36N/A-44.67
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.001.001.001.001.011.001.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
-1.03%-1.40%-1.69%-2.69%-2.75%-2.56%-2.38%-1.06%-0.94%-0.89%N/A-2.75%